Full Text View
Tabular View
No Study Results Posted
Related Studies
Topotecan in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment
This study has been completed.
Study NCT00005811   Information provided by National Cancer Institute (NCI)
First Received: June 2, 2000   Last Updated: February 14, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia
Lymphoma
Metastatic Cancer
Additional conditions recognized in this trial
Central Nervous System Neoplasms
Neoplasm Metastasis
Nervous System Neoplasms
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplastic Processes
Nervous System Diseases
Pathologic Processes
Interventions listed in this trial
topotecan hydrochloride
Additional drug interventions recognized in this trial
Topotecan
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Children's Oncology Group
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services